Endo Oxymorphone Documents Subpoenaed

Endo says a Florida U.S. attorney has subpoenaed documents and information relating to products containing oxymorphone. “The subpoena broadly requests documents including, among others, those produced in past or pending lawsuits and those relating to product safety and efficacy, overdoses, diversion, thefts, overprescribing, dependency or tolerance, withdrawal addictiveness, adverse events, and manipulation,” Endo says. “The subpoena also requests distribution and other third-party agreements, together with sales and marketing, training, financial, compensation, and corporate information, as well as documents relating to interactions with various government agencies, including FDA, the Drug Enforcement Administration, Veterans Administration, Federal Trade Commission, HHS, Medicare, Medicaid.”

The company says it intends to be responsive to the subpoena and cooperate with any related government investigation.